✦ LIBER ✦

Adoptive Immunotherapy to Prevent and Treat HHV-6 Reactivation Post Allogenic Stem Cell Transplant

✍ Scribed by U. Gerdemann; L. Keukens; U.L. Katari; J.M. Keirnan; A.P. de Pagter; H.E. Heslop; C.M. Rooney; A.M. Leen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adoptive immunotherapy to treat leukemic

✍ Beverley M. Kerr; Andy Kang-Wei Hsu; Kathryn L. Jones; Alison M. Rice 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 287 KB

Multivirus-Specific T Cell Immunotherapy

✍ A.M. Leen; U. Gerdemann; A. Christin; C.A. Ramos; H.E. Heslop; M.K. Brenner; C.M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Immune-Modulating Drugs and Hypomethylat

✍ Kröger, Nicolaus; Stübig, Thomas; Atanackovic, Djordje 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Risk Factors for Developing Human Herpes

✍ Akiko Yamane; Takehiko Mori; Shigeaki Suzuki; Ai Mihara; Rie Yamazaki; Yoshinobu 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Strategies to Prevent EBV Reactivation a

✍ Nishitha Reddy; Katayoun Rezvani; A. John Barrett; Bipin N. Savani 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Tetramer monitoring to assess risk facto

✍ S. Borchers; S. Luther; U. Lips; N. Hahn; J. Kontsendorn; M. Stadler; S. Buchhol 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB